Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.36 |
| ▸ | GPR3 | P46089 | 1/20 | 0.35 |
| ▸ | MAPK8 | P45983 | 2/20 | 0.35 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | BACE1 | P56817 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13754821 | 0.85 | F2 (0.39) | KDM4EL3MBTL1ATMPTPN1KMT2A | |
| SCHEMBL12551579 | 0.84 | KDM4E (0.56) | KDM4EL3MBTL1ATMCYP1A2CYP2C19 | |
| SCHEMBL64816 | 0.83 | KDM4E (0.71) | KDM4EL3MBTL1ATMCYP1A2CYP2C19 | |
| SCHEMBL29362582 | 0.83 | KDM4E (0.71) | KDM4EL3MBTL1ATMCYP1A2CYP2C19 | |
| SCHEMBL23534547 | 0.83 | KDM4E (0.71) | KDM4EL3MBTL1ATMCYP1A2CYP2C19 | |
| SCHEMBL38818 | 0.82 | L3MBTL1 (0.59) | KDM4EL3MBTL1ATMCYP1A2CYP2C19 | |
| SCHEMBL2758572 | 0.81 | L3MBTL1 (0.62) | KDM4EL3MBTL1ATMCYP1A2CYP2C19 | |
| SCHEMBL13815322 | 0.81 | KDM4E (0.52) | KDM4EL3MBTL1ATMCYP1A2CYP2C19 | |
| SCHEMBL3664509 | 0.81 | KDM4E (0.57) | KDM4EL3MBTL1ATMCYP1A2CYP2C19 | |
| SCHEMBL16605606 | 0.79 | L3MBTL1 (0.60) | KDM4EL3MBTL1ATMCYP1A2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8124767-B2 | Luminescence biotin-transition metal complex conjugate, and method of amplifying signal using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2012-02-28 | — | — | US | disclosed |
| US-8124767-B2 | Luminescence biotin-transition metal complex conjugate, and method of amplifying signal using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2012-02-28 | — | — | US | disclosed |
| US-20090209048-A1 | Luminescence Biotin-Transition Metal Complex Conjugate, and Method of Amplifying Signal Using the Same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2009-08-20 | — | — | US | disclosed |
| US-20090209048-A1 | Luminescence Biotin-Transition Metal Complex Conjugate, and Method of Amplifying Signal Using the Same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2009-08-20 | — | — | US | disclosed |
| US-7575818-B2 | Organic metal compounds in which compounds for host and compounds for dopant are connected, organic electroluminesence display devices using the compounds and method for preparation of the devices | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2009-08-18 | — | — | US | disclosed |
| US-7541100-B2 | Organic metal compounds in which compounds for host and compounds for dopant are connected, organic electroluminesence display devices using the compounds and method for preparation of the devices | SAMSUNG DISPLAY CO., LTD. (KR) | 2009-06-02 | — | — | US | disclosed |
| US-7541100-B2 | Organic metal compounds in which compounds for host and compounds for dopant are connected, organic electroluminesence display devices using the compounds and method for preparation of the devices | SAMSUNG DISPLAY CO., LTD. (KR) | 2009-06-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090209048-A1 | Luminescence Biotin-Transition Metal Complex Conjugate, and Method of Amplifying Signal Using the Same | BTD, HLCS, BPGM | KDM4E 4258/4885L3MBTL1 503/4885ATM 3338/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.